Bursa Malaysia (BURSA MK) : Regional Morning Notes

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 5

R e g i o n a l M o r n i n g N o t e s Wednesday, 28 April 2021

COMPANY RESULTS HOLD


Bursa Malaysia (BURSA MK) (Maintained)
1Q21: Earnings Better Than Expected; Robust ADV Priced In Share Price RM8.49
Target Price RM9.10
Bursa reported better-than-expected earnings in 1Q21 on the back of robust securities
ADV growth. We think the current risk-to-reward is balanced with the stock trading at - Upside +7.2%
1SD to historical mean PE on record 2021 ADV assumptions. As such, despite our
earnings upgrade to factor in the robust near-term ADV assumptions, we are
maintaining our HOLD rating and target price of RM9.10. Entry price: RM8.20. COMPANY DESCRIPTION
Bursa is a fully integrated stock exchange
1Q21 RESULTS offering a wide range of exchange-related
Year to 31 Dec (RMm) 1Q21 4Q20 qoq % chg 1Q20 yoy % chg services. It also offers information services
Total Revenue 232.3 230.7 0.7 150.8 54.1 related to the Malaysian securities market
EBITDA 168.1 144.5 16.3 92.8 81.1 STOCK DATA
EBITDA margin (%) 73.7% 64.3% 9.5 63.8% 9.9
GICS sector Financials
PBT 162.8 139.2 17.0 87.1 86.8
Bloomberg ticker: BURSA MK
Net Profit 121.4 104.9 15.8 64.7 87.5
EPS (sen) 15.0 13.0 15.8 8.0 87.6 Shares issued (m): 809.0
Average daily trading value (RMb) 5.17 4.98 3.8 2.58 100.4 Market cap (RMm): 6,870.9
Average daily trading volume (b ) 8.60 9.13 (5.8) 3.50 145.7 Market cap (US$m): 1,676.8
Source: Bursa, UOB Kay Hian 3-mth avg daily t'over (US$m): 5.5
RESULTS Price Performance (%)
• Above expectations. Bursa Malaysia (Bursa) reported 1Q21 net profit of RM121.4m 52-week high/low RM10.60/RM4.42
(87.5% yoy, 15.8% qoq). Earnings were above our and consensus estimates with 1Q21 1mth 3mth 6mth 1yr YTD
earnings representing 37% and 40% of our and consensus full-year forecasts respectively. (5.1) (6.7) 0.5 49.0 3.2
The positive deviation was due to stronger-than-expected trading revenue, buoyed by
Major Shareholders %
stronger-than-expected 1Q21 ADV of RM5.03b vs our full-year 2020 forecast of RM3.60b.
Capital Market Development Fund 18.6
• Robust ADV underpins record-high earnings. Bursa reported a near record-high 1Q21 Kumpulan Wang Persaraan 11.2
earnings, largely driven by a 93% yoy increase in securities trading revenue as ADV rose EPF 6.7
100.3% yoy to RM5.03b. However, earnings were partially tempered by a 16% yoy
FY21 NAV/Share (RM) 1.14
contraction in derivative trading revenue on lower FCPO futures contract volumes.
FY21 Net Cash/Share (RM) 0.39
• On a qoq comparison, earnings rose 15.8% qoq largely driven by lower opex (-50% qoq),
partially due to 4Q20’s lumpy IT and other non-staff expenses. Revenue was flattish as a 5% PRICE CHART
qoq increase in securities market ADV was offset by a lower number of trading days and
(lcy) BU R SA MAL AY SIA BHD BU R SA MALAY SIA BHD /FBMK LC I IN DE X (%)
weaker listing and issuer fee income. 11 190
180
10
170
160
9
150

KEY FINANCIALS 8 140


130
Year to 31 Dec (RMm) 2019 2020 2021F 2022F 2023F 7
120

Net turnover 502 799 808 704 644 6


110
100
EBITDA 277 529 529 411 336 5 90
Operating profit 256 507 511 393 318 15
Volume (m)
Net profit (rep./act.) 183 378 377 290 234 10

5
Net profit (adj.) 183 378 377 290 234
0
EPS (sen) 22.6 46.7 46.6 35.9 28.9 Apr 20 Jun 20 Aug 20 Oct 20 Dec 20 Feb 21

PE (x) 37.6 18.2 18.2 23.7 29.4


P/B (x) 9.0 7.6 7.5 7.3 7.3 Source: Bloomberg
EV/EBITDA (x) 23.7 12.4 12.4 16.0 19.5
ANALYST(S)
Dividend yield (%) 2.4 6.0 5.2 4.0 3.2
Net margin (%) 36.3 47.3 46.6 41.2 36.3 Keith Wee Teck Keong
Net debt/(cash) to equity (%) (32.0) (47.8) (34.5) (37.1) (39.4) +603 2147 1981
Interest cover (x) 518.9 982.5 n.a. n.a. n.a. keithwee@uobkayhian.com
ROE (%) 22.3 45.5 41.4 31.3 24.9
Consensus net profit - - 335 302 296
UOBKH/Consensus (x) - - 1.13 0.96 0.79
Source: Bursa, Bloomberg, UOB Kay Hian

Refer to last page for important disclosures. 24


1
R e g i o n a l M o r n i n g N o t e s Wednesday, 28 April 2021

STOCK IMPACT PE BAND


• Risk-to-reward is balanced. Given the very high-base effect of 2020 and 2021 ADV of
RM4.2b and RM4.3b (f), earnings would be largely flattish in 2021 before normalising
downwards from 2022 onwards. As such, we believe that the stock’s current risk-to-reward is
balanced, which prompts us to maintain our HOLD recommendation despite our earnings
upgrade on a stronger-than-expected near-term ADV outlook.
• Raising ADV assumptions. We raise our 2021 and 2022 ADV assumptions to RM4.3b and
RM3.3b respectively from RM3.6b and RM3.0b as trading volumes continues to surprise on
the upside (4M21 ADV: RM4.7b).
BURSA: SHARE PRICE VS ADV

Source: Bursa, UOB Kay Hian

TRADING VALUE

Source: Bloomberg, UOB Kay Hian

EARNINGS REVISION/RISK
Source: Bursa, UOB Kay Hian
• Factoring in higher ADV assumptions for 2021 and 2022, we raise our earnings by 14% and
7% respectively. KEY ASSUMPTIONS
2021F 2022F 2023F
VALUATION/RECOMMENDATION Average Daily Value of Equities (RMb) 4.30 3.30 2.50
Futures Contract (m) 19.1 19.6 20.1
• Maintain HOLD with an unchanged target price of RM9.10. The stock is currently trading Dividend payout ratio (%) 95.0 95.0 95.0
at -1SD to its historical 10-year mean PE on near-record earnings assumptions for 2021. We Source: UOB Kay Hian
think that this fair as 2021 earnings assumptions are based on extremely lofty ADV
assumptions of RM4.3b, which are unlikely to be sustainable over the medium term.
Consequently, we are maintaining our HOLD recommendation and target price of RM9.10
based on 22x (-0.5SD below historical mean) 2021 and 2022 blended average earnings
forecast. By capturing the average of the two years’ earnings forecasts into our valuation, we
believe that we would be striking a balance in acknowledging the robust near-term ADV
outlook and a more realistic downward normalisation in ADV in 2022.

Refer to last page for important disclosures. 25


2
R e g i o n a l M o r n i n g N o t e s Wednesday, 28 April 2021

PROFIT & LOSS BALANCE SHEET


Year to 31 Dec (RMm) 2020 2021F 2022F 2023F Year to 31 Dec (RMm) 2020 2021F 2022F 2023F
Net turnover 799.0 808.2 704.3 643.6 Fixed assets 197.4 229.4 261.4 293.4
EBITDA 528.6 528.9 411.1 335.7 Other LT assets 263.4 317.8 278.8 290.8
Deprec. & amort. 21.4 18.0 18.0 18.0 Cash/ST investment 439.0 325.2 354.4 380.5
EBIT 507.2 510.9 393.1 317.7 Other current assets 2,333.1 2,314.9 2,284.2 2,258.4
Net interest income/(expense) (0.5) 0.0 0.0 0.0 Total assets 3,232.9 3,187.3 3,178.9 3,223.2
Pre-tax profit 506.6 510.9 393.1 317.7 ST debt 0.5 0.0 0.0 0.0
Tax (128.9) (129.8) (99.9) (80.7) Other current liabilities 2,303.8 2,202.5 2,149.9 2,153.0
Minorities 0.0 (4.2) (3.2) (3.2) LT debt 7.5 7.5 7.5 7.5
Net profit 377.7 376.9 290.1 233.8 Other LT liabilities 20.3 53.5 80.0 106.3
Net profit (adj.) 377.7 376.9 290.1 233.8 Shareholders' equity 900.8 919.6 934.1 945.8
Minority interest 0.0 4.2 7.4 10.6
Total liabilities & equity 3,232.9 3,187.3 3,178.9 3,223.2

CASH FLOW KEY METRICS


Year to 31 Dec (RMm) 2020 2021F 2022F 2023F Year to 31 Dec (%) 2020 2021F 2022F 2023F
Operating 417.2 446.3 352.8 296.3 Profitability
Pre-tax profit 377.7 381.1 293.3 237.0 EBITDA margin 66.2 65.4 58.4 52.2
Deprec. & amort. 21.8 18.0 18.0 18.0 Pre-tax margin 63.4 63.2 55.8 49.4
Working capital changes (1.7) 14.0 15.0 15.0 Net margin 47.3 46.6 41.2 36.3
Non-cash items 19.4 33.2 26.5 26.3 ROA 13.6 11.7 9.1 7.3
Investing (90.5) (50.0) (50.0) (50.0) ROE 45.5 41.4 31.3 24.9
Capex (maintenance) (40.4) (50.0) (50.0) (50.0)
Investments (149.3) 0.0 0.0 0.0 Growth
Others 99.2 0.0 0.0 0.0 Turnover 59.0 1.2 (12.8) (8.6)
Financing (225.6) (358.6) (275.6) (222.1) EBITDA 90.8 0.1 (22.3) (18.3)
Dividend payments (177.8) (358.1) (275.6) (222.1) Pre-tax profit 100.7 0.8 (23.1) (19.2)
Issue of shares 0.0 0.0 0.0 0.0 Net profit 106.9 (0.2) (23.0) (19.4)
Loan repayment 0.0 (0.5) 0.0 0.0 Net profit (adj.) 106.9 (0.2) (23.0) (19.4)
Others/interest paid (47.9) 0.0 0.0 0.0 EPS 106.9 (0.2) (23.0) (19.4)
Net cash inflow (outflow) 101.1 37.7 27.2 24.2
Beginning cash & cash equivalent 185.9 286.4 325.2 354.4 Leverage
Ending cash & cash equivalent 287.0 324.2 352.4 378.5 Debt to total capital 0.9 0.8 0.8 0.8
Debt to equity 0.9 0.8 0.8 0.8
Net debt/(cash) to equity (47.8) (34.5) (37.1) (39.4)
Interest cover (x) n.a. n.a. n.a. n.a.

Refer to last page for important disclosures. 26


3
R e g i o n a l M o r n i n g N o t e s Wednesday, 28 April 2021

Disclosures/Disclaimers

This report is prepared by UOB Kay Hian Private Limited (“UOBKH”), which is a holder of a capital markets services licence and an
exempt financial adviser in Singapore.

This report is provided for information only and is not an offer or a solicitation to deal in securities or to enter into any legal relations, nor an
advice or a recommendation with respect to such securities.

This report is prepared for general circulation. It does not have regard to the specific investment objectives, financial situation and the
particular needs of any recipient hereof. Advice should be sought from a financial adviser regarding the suitability of the investment
product, taking into account the specific investment objectives, financial situation or particular needs of any person in receipt of the
recommendation, before the person makes a commitment to purchase the investment product.

This report is confidential. This report may not be published, circulated, reproduced or distributed in whole or in part by any recipient of this
report to any other person without the prior written consent of UOBKH. This report is not directed to or intended for distribution to or use by
any person or any entity who is a citizen or resident of or located in any locality, state, country or any other jurisdiction as UOBKH may
determine in its absolute discretion, where the distribution, publication, availability or use of this report would be contrary to applicable law
or would subject UOBKH and its connected persons (as defined in the Financial Advisers Act, Chapter 110 of Singapore) to any
registration, licensing or other requirements within such jurisdiction.

The information or views in the report (“Information”) has been obtained or derived from sources believed by UOBKH to be reliable.
However, UOBKH makes no representation as to the accuracy or completeness of such sources or the Information and UOBKH accepts
no liability whatsoever for any loss or damage arising from the use of or reliance on the Information. UOBKH and its connected persons
may have issued other reports expressing views different from the Information and all views expressed in all reports of UOBKH and its
connected persons are subject to change without notice. UOBKH reserves the right to act upon or use the Information at any time,
including before its publication herein.

Except as otherwise indicated below, (1) UOBKH, its connected persons and its officers, employees and representatives may, to the
extent permitted by law, transact with, perform or provide broking, underwriting, corporate finance-related or other services for or solicit
business from, the subject corporation(s) referred to in this report; (2) UOBKH, its connected persons and its officers, employees and
representatives may also, to the extent permitted by law, transact with, perform or provide broking or other services for or solicit business
from, other persons in respect of dealings in the securities referred to in this report or other investments related thereto; (3) the officers,
employees and representatives of UOBKH may also serve on the board of directors or in trustee positions with the subject corporation(s)
referred to in this report. (All of the foregoing is hereafter referred to as the “Subject Business”); and (4) UOBKH may otherwise have an
interest (including a proprietary interest) in the subject corporation(s) referred to in this report.

As of the date of this report, no analyst responsible for any of the content in this report has any proprietary position or material interest in
the securities of the corporation(s) which are referred to in the content they respectively author or are otherwise responsible for.

IMPORTANT DISCLOSURES FOR U.S. PERSONS

This research report was prepared by UOBKH, a company authorized, as noted above, to engage in securities activities in Singapore.
UOBKH is not a registered broker-dealer in the United States and, therefore, is not subject to U.S. rules regarding the preparation of
research reports and the independence of research analysts. This research report is provided for distribution by UOBKH (whether directly
or through its US registered broker dealer affiliate named below) to “major U.S. institutional investors” in reliance on the exemption from
registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”). All US persons that
receive this document by way of distribution from or which they regard as being from UOBKH by their acceptance thereof represent and
agree that they are a major institutional investor and understand the risks involved in executing transactions in securities.

Any U.S. recipient of this research report wishing to effect any transaction to buy or sell securities or related financial instruments based on
the information provided in this research report should do so only through UOB Kay Hian (U.S.) Inc (“UOBKHUS”), a registered broker-
dealer in the United States. Under no circumstances should any recipient of this research report effect any transaction to buy or sell
securities or related financial instruments through UOBKH.

UOBKHUS accepts responsibility for the contents of this research report, subject to the terms set out below, to the extent that it is
delivered to and intended to be received by a U.S. person other than a major U.S. institutional investor.

The analyst whose name appears in this research report is not registered or qualified as a research analyst with the Financial Industry
Regulatory Authority (“FINRA”) and may not be an associated person of UOBKHUS and, therefore, may not be subject to applicable
restrictions under FINRA Rules on communications with a subject company, public appearances and trading securities held by a research
analyst account.

Refer to last page for important disclosures. 54


4
R e g i o n a l M o r n i n g N o t e s Wednesday, 28 April 2021

Analyst Certification/Regulation AC

Each research analyst of UOBKH who produced this report hereby certifies that (1) the views expressed in this report accurately reflect
his/her personal views about all of the subject corporation(s) and securities in this report; (2) the report was produced independently by
him/her; (3) he/she does not carry out, whether for himself/herself or on behalf of UOBKH or any other person, any of the Subject Business
involving any of the subject corporation(s) or securities referred to in this report; and (4) he/she has not received and will not receive any
compensation that is directly or indirectly related or linked to the recommendations or views expressed in this report or to any sales,
trading, dealing or corporate finance advisory services or transaction in respect of the securities in this report. However, the compensation
received by each such research analyst is based upon various factors, including UOBKH’s total revenues, a portion of which are
generated from UOBKH’s business of dealing in securities.

Reports are distributed in the respective countries by the respective entities and are subject to the additional restrictions listed in the
following table.
General This report is not intended for distribution, publication to or use by any person or entity who is a citizen or resident of or
located in any country or jurisdiction where the distribution, publication or use of this report would be contrary to
applicable law or regulation.
Hong Kong This report is distributed in Hong Kong by UOB Kay Hian (Hong Kong) Limited ("UOBKHHK"), which is regulated by the
Securities and Futures Commission of Hong Kong. Neither the analyst(s) preparing this report nor his associate, has
trading and financial interest and relevant relationship specified under Para. 16.4 of Code of Conduct in the listed
corporation covered in this report. UOBKHHK does not have financial interests and business relationship specified under
Para. 16.5 of Code of Conduct with the listed corporation covered in this report. Where the report is distributed in Hong
Kong and contains research analyses or reports from a foreign research house, please note:
(i) recipients of the analyses or reports are to contact UOBKHHK (and not the relevant foreign research house) in Hong
Kong in respect of any matters arising from, or in connection with, the analysis or report; and
(ii) to the extent that the analyses or reports are delivered to and intended to be received by any person in Hong Kong
who is not a professional investor, or institutional investor, UOBKHHK accepts legal responsibility for the contents of the
analyses or reports only to the extent required by law.
Indonesia This report is distributed in Indonesia by PT UOB Kay Hian Sekuritas, which is regulated by Financial Services Authority
of Indonesia (“OJK”). Where the report is distributed in Indonesia and contains research analyses or reports from a
foreign research house, please note recipients of the analyses or reports are to contact PT UOBKH (and not the relevant
foreign research house) in Indonesia in respect of any matters arising from, or in connection with, the analysis or report.
Malaysia Where the report is distributed in Malaysia and contains research analyses or reports from a foreign research house, the
recipients of the analyses or reports are to contact UOBKHM (and not the relevant foreign research house) in Malaysia,
at +603-21471988, in respect of any matters arising from, or in connection with, the analysis or report as UOBKHM is the
registered person under CMSA to distribute any research analyses in Malaysia.
Singapore This report is distributed in Singapore by UOB Kay Hian Private Limited ("UOBKH"), which is a holder of a capital
markets services licence and an exempt financial adviser regulated by the Monetary Authority of Singapore.Where the
report is distributed in Singapore and contains research analyses or reports from a foreign research house, please note:
(i) recipients of the analyses or reports are to contact UOBKH (and not the relevant foreign research house) in Singapore
in respect of any matters arising from, or in connection with, the analysis or report; and
(ii) to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore
who is not an accredited investor, expert investor or institutional investor, UOBKH accepts legal responsibility for the
contents of the analyses or reports only to the extent required by law.
Thailand This report is distributed in Thailand by UOB Kay Hian Securities (Thailand) Public Company Limited, which is regulated
by the Securities and Exchange Commission of Thailand.
United This report is being distributed in the UK by UOB Kay Hian (U.K.) Limited, which is an authorised person in the meaning
Kingdom of the Financial Services and Markets Act and is regulated by The Financial Conduct Authority. Research distributed in
the UK is intended only for institutional clients.
United This report cannot be distributed into the U.S. or to any U.S. person or entity except in compliance with applicable U.S.
States of laws and regulations. It is being distributed in the U.S. by UOB Kay Hian (US) Inc, which accepts responsibility for its
America contents. Any U.S. person or entity receiving this report and wishing to effect transactions in any securities referred to in
(‘U.S.’) the report should contact UOB Kay Hian (US) Inc. directly.

Copyright 2021, UOB Kay Hian Pte Ltd. All rights reserved.

http://research.uobkayhian.com

RCB Regn. No. 197000447W

Refer to last page for important disclosures. 55


5

You might also like